drugset / Trial / NCT03719482
Assessment of the Biodistribution and Safety of [18F]MNI-1054
NaSingle-groupOpen-labelOther
Summary
The overall goal of this protocol is to evaluate the biodistribution of \[18F\]MNI-1054 as a LSD1 targeted radiopharmaceutical.
Timeline
- Start
- 2018-10-05
- Primary completion
- 2019-05-02
- Completion
- 2019-05-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]MNI-1054 | Diagnostic / imaging agent | — | — |
Indications
No indication recorded.